Enliven Therapeutics
ELVN
#5145
Rank
A$2.31 B
Marketcap
A$38.97
Share price
-2.98%
Change (1 day)
7.66%
Change (1 year)

Enliven Therapeutics (ELVN) - Net assets

Net assets on the balance sheet as of September 2025 : A$0.68 Billion

According to Enliven Therapeutics's latest financial reports the company has A$0.68 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Enliven Therapeutics - Net assets on balance sheet (from 2021 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$A$0.49 B38.01%
2023-12-31$A$0.36 B-419.71%
2022-12-31$-A$0.12 Billion90.84%
2021-12-31$-A$59.16 Million124.03%
2020-12-31$-A$26.41 Million